Autopsy report · NCT01944969

Long-term Safety and Tolerability Study of Brexpiprazole as Adjunctive Treatment in Patients With Major Depressive Disorder

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“The study was terminated because the lead-in study (14571A) in elderly was terminated; see Detailed Description.”

The sponsor’s own words in the registry.

Life of this trial

Registered 1 month before it started.
Ran for about 7 months before it stopped.
26 participants enrolled.
Results were posted on the registry 1 year 10 months after it ended.

Vital statistics

Status: Terminated
Phase: Phase 3
Sponsor: H. Lundbeck A/S
Sponsor type: Industry
Conditions: Major Depressive Disorder
Interventions: Brexpiprazole
Participants: 26
Sites: 1
Countries: United States

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.